ProEncia Biotechnology
Developing next-generation, non-invasive periodontal disease treatments.
About
ProEncia Biotechnology is a biopharma startup focused on creating novel, non-invasive products for the treatment and commercialization of periodontal disease. Their pipeline aims to address patients suffering from periodontal disease at all stages of severity.
Technology stack
detected 2026-06-16Est. monthly stack spend~$70/mo
Email
Google Workspace
Stack
Squarespace
SquarespaceComments
No comments yet. Be the first to share your take.
Frequently asked
What does ProEncia Biotechnology do?
ProEncia Biotechnology is a biopharma startup focused on creating novel, non-invasive products for the treatment and commercialization of periodontal disease. Their pipeline aims to address patients suffering from periodontal disease at all stages of severity.
Where is ProEncia Biotechnology headquartered?
ProEncia Biotechnology is headquartered in Minneapolis, Minnesota, USA.
When was ProEncia Biotechnology founded?
ProEncia Biotechnology was founded in 2019.
What industry does ProEncia Biotechnology operate in?
ProEncia Biotechnology operates in Biotechnology, Pharmaceuticals, Healthcare, Biotech, MedTech, HealthTech.
How many employees does ProEncia Biotechnology have?
ProEncia Biotechnology has approximately 5 people on record.